Professor Doreen Cantrell, Head of the College of Life Sciences and Vice-Principal of the University of Dundee, has been elected a Fellow of the Royal Society.
Professor Cantrell is one of 44 new Fellows and eight new Foreign Members elected to the Royal Society, the UK’s national academy of science. She has been recognized for her internationally renowned work in the field of immunology.
Sir Paul Nurse, President of the Royal Society and Nobel Laureate said, “It is a true pleasure to welcome this year’s new Fellows to the Royal Society. They join the ranks of the UK and Commonwealth’s leading scientists, counting themselves among early Fellows such as Isaac Newton, Robert Boyle and Charles Darwin. The Society aims to expand the frontiers of knowledge by championing the development and use of science, mathematics, engineering and medicine for the benefit of humanity and the good of the planet. It is the contribution of excellent individuals such as these which makes this possible.”
Professor Cantrell’s election bring the number of Fellows of the Royal Society in the College of Life Sciences at Dundee to 10, one of the highest concentrations of Fellows in the UK.
“I am delighted that Doreen Cantrell, our Head of College, has been recognised by the Royal Society for her outstanding research in immunology,” said Professor Mike Ferguson, Dean of Research in the College of Life Sciences. “This honour is richly deserved and a great tribute to Doreen and her talented team. This personal honour for Doreen comes hot on the heels of the College's national 'Excellence with Impact' Award given by the Biotechnology and Biological Sciences Research Council which recognised the College of Life Sciences for 'the greatest delivery of impact' among UK Bioscience research departments.”
Professor Cantrell, who also holds a position as a Wellcome Trust Principal Research Fellow in the College, is known internationally for her work on T lymphocyte development and activation, which are key to the comprehension and manipulation of immune responses. She is noted for her multidisciplinary approach and the enlightened combination of biochemical, cell biological, transgenic and gene knock-out technologies.